News

Researchers at IMBA - Institute for Molecular Biotechnology of the Austrian Academy of Sciences – describe “adaptive radiation” of RNA export…

07 Aug'19

a:head bio AG, an Austrian biotech company focusing on the development of next generation therapeutics for the treatment of brain disorders based on…

02 Aug'19

Professor Hans Tuppy, born in 1924, started his studies in Chemistry at a time when Europe was struck by World War II. The war took both his father…

01 Aug'19

Valneva regains control of key R&D assets, strengthens financial outlook with $23 million CEPI chikungunya grant

29 Jul'19

Valneva SE (“Valneva” or “the Company”), a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs,…

25 Jul'19

Valneva SE (“Valneva”), a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs, and the Coalition…

23 Jul'19

Advances in sequencing technology have allowed scientists to peer inside living cells and follow the fate of small RNAs. The expedition has uncovered…

22 Jul'19

Researchers at IMBA-Institute of Molecular Biotechnology of the Austrian Academy of Sciences show how neural stem cells determine their “age”, or…

22 Jul'19

The VDRC is with 27.000 RNAi lines of Drosophila melanogaster, which cover 91 % of the whole genome, the largest center providing RNAi lines…

16 Jul'19

Valneva SE (“Valneva” or “the Company”), a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs,…

14 Jul'19

Phase 1/2 trial to be HOOKIPA’s first clinical trial in immuno-oncology

12 Jul'19

Mitosis is the process by which the genetic information encoded on chromosomes is equally distributed to two daughter cells, a fundamental feature of…

Upcycling of proteins protects DNA from parasites

a:head - launched to transform CNS drug discovery

"Science is my life" - Interview with Professor Hans Tuppy

Valneva Reports H1 2019 Results Marked by Strong Operational Performance and Major Corporate Progress

Valneva Announces Formation of Scientific Advisory Board

CEPI awards up to US$23.4 million to Valneva for late-stage development of a single-dose Chikungunya vaccine

Time-resolved sequencing tells the life story of small RNAs

How does a neural stem cell know its age?

Vienna Drosophila Resource Center provides unique services helping to investigate genes' function

Valneva Announces Drawdown of Further €10 million from its Existing European Investment Bank Loan

HOOKIPA Announces FDA Clearance of IND Application for HB-201 Clinical Trial to Treat HPV-Positive Cancers

Centrioles - critical players in cell division